Tuesday, August 12, 2025
HomePharma

Pharma

Pharma

Leading Sleep Medicine Expert Joins Apnimed Management Team

Life Sciences Times - 0
Pharma

BeiGene Closes Collaboration with Novartis to Develop Anti-PD-1 Antibody Tislelizumab

Life Sciences Times - 0
Pharma

MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery

Life Sciences Times - 0
Pharma

Update On IGC’s Phase 1 Clinical Trial on Alzheimer’s Patients

Life Sciences Times - 0
Pharma

Xlife Sciences AG: Antiviral drug candidate for SARS-CoV-2

Life Sciences Times - 0
Pharma

M6P Therapeutics Presents Promising Preclinical Data in Lysosomal Storage Disorders at the 17th Annual WORLDSymposium™ 2021

Life Sciences Times - 0
Pharma

Drug Topics® Announces Partnership with inPharmacyJobs

Life Sciences Times - 0
Pharma

New Zealand approves 1st Covid-19 vaccine

Life Sciences Times - 0
Pharma

Global Anti-inflammatory Drugs Market to Surpass US$ 142,223.4 Million by 2027, Says Coherent Market Insights

Life Sciences Times - 0
Pharma

COVAXX’s COVID-19 Vaccine, UB-612, Induced Neutralizing Antibodies in 100% of Participants During Phase 1 Clinical Trial

Life Sciences Times - 0
Pharma

AstraZeneca’s anti-diabetic drug gets nod for kidney disease in India

Life Sciences Times - 0
Pharma

Reverie Labs Raises $25 Million Series A Round

Life Sciences Times - 0
1...717273...76Page 72 of 76

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv